Coronary Artery Disease in Patients with Aortic Stenosis and Transcatheter Aortic Valve Implantation: Implications for Management.

Autor:	de Azevedo Filho AF; Department of Valvular Heart Disease, Heart Institute (InCor), University of São Paulo São Paulo, Brazil., Accorsi TA; Department of Valvular Heart Disease, Heart Institute (InCor), University of São Paulo São Paulo, Brazil.; Samaritano Paulista Hospital São Paulo, Brazil., Ribeiro HB; Samaritano Paulista Hospital São Paulo, Brazil.; Interventional Cardiology Department, Heart Institute (InCor), University of São Paulo São Paulo, Brazil.
Jazyk:	angličtina
Zdroj:	European cardiology [Eur Cardiol] 2021 Dec 07; Vol. 16, pp. e49. Date of Electronic Publication: 2021 Dec 07 (Print Publication: 2021).
DOI:	10.15420/ecr.2021.27
Abstrakt:	Aortic valve stenosis (AS) is the most common valvular heart disease among elderly patients. Since the pathophysiology of degenerative AS shares common pathways with atherosclerotic disease, the severity of AS in the elderly population is often concurrent to the presence of coronary artery disease (CAD). Although surgical aortic valve replacement has been the standard treatment for severe AS, the high operative morbidity and mortality in complex and fragile patients was the trigger to develop less invasive techniques. Transcatheter aortic valve implantation (TAVI) has been posed as the standard of care for elderly patients with severe AS with various risk profiles, which has meant that the concomitant management of CAD has become a crucial issue in such patients. Given the lack of randomised controlled trials evaluating the management of CAD in TAVI patients, most of the recommendations are based on retrospective cohort studies so that the Heart Team approach - together with an assessment of multiple parameters including symptoms and clinical characteristics, invasive and non-invasive ischaemic burden and anatomy - are crucial for the proper management of these patients. This article provides a review of current knowledge about assessment and therapeutic approaches for CAD and severe AS in patients undergoing TAVI. Competing Interests: Disclosure: The authors have no conflicts of interest to declare. (Copyright © 2021, Radcliffe Cardiology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu